Professor Elke de Jong graduated and completed her dermatology residency at the Medical School at the University Medical Centre in St. Radboud, Nijmegen, The Netherlands. She is the author or co-author of more than 140 publications, and she guided or assisted 13 research fellows in composing their thesis. Her main research topic in dermatology is psoriasis and autoimmune disease, especially the efficacy and safety of systemic treatments for psoriasis. She established a registry on biologic treatment in the daily practice for psoriasis. She has served as a Board member and secretary for the National Board of the Dutch Association of Dermatologists (NVDV), as a member and treasurer of the Board of the Dutch and Belgian CME Dermatology and Venereology (SNNDV). She is also a member of the National Advisory Board for Immunodermatoses and was involved in the development of national guidelines for vasculitis and the systemic treatment of psoriasis. She has experience with over 100 studies since 1989.
Areas of Interest
Psoriasis real world evidence, pragmatic trials, RCT,s biomarkers, dosing, pharmacogenetics, immuno-profiling, and psoriatic arthritis.